Advanced IV Cancer Therapy

Learn From the Clinical Experience of Dr. Stephen Petteruti

Dr. Stephen Petteruti, a board-certified physician with extensive experience in functional, metabolic, anti-aging, and integrative medicine, leads this course. Throughout his career, Dr. Petteruti has emphasized identifying factors influencing health beyond isolated diagnoses. His clinical approach integrates metabolic health, inflammation, immune function, hormonal balance, nutrition, and quality of life with conventional medical care.

Dr. Petteruti has significant experience developing and managing advanced IV therapy programs. His clinical practice includes high-dose IV vitamin C, alpha-lipoic acid, nutritional infusions, mistletoe therapy, and other supportive treatments for complex cases. This direct experience informs the course content and enables him to address practical challenges providers encounter when translating research into clinical practice.

This training was developed to address the need for practical skills in integrative cancer therapy that extend beyond theoretical knowledge. Providers must determine appropriate candidates, conduct necessary pre-treatment testing, make informed dosing decisions, recognize reactions requiring intervention, and know when to modify or discontinue therapy.

Dr. Petteruti also contributes the perspective of a practice owner and medical educator. He is familiar with the clinical, operational, documentation, and patient communication requirements necessary for responsible delivery of advanced therapies. The course incorporates insights from years of patient care, protocol development, research review, and healthcare professional training.

What You Will Learn

The course offers a comprehensive review of high-dose intravenous vitamin C in integrative cancer care. You will examine proposed mechanisms, clinical applications, baseline testing requirements, patient selection criteria, contraindications, dosing strategies, infusion procedures, and monitoring protocols. The training also covers laboratory interpretation and clinical factors influencing treatment suitability for individual patients.

The curriculum addresses mistletoe therapy (Viscum album), providing guidance on patient selection, administration routes, dose escalation, anticipated local and systemic reactions, monitoring, and treatment planning. You will learn about its use as a complementary therapy and how to assess its potential role within a comprehensive support plan.

The section on alpha-lipoic acid explores its biochemical functions, proposed metabolic applications, and integration into clinical protocols. You will review safety considerations, dosing strategies, potential interactions, and the clinical rationale for combining alpha-lipoic acid with other supportive therapies.

The course also examines selected repurposed medications currently under investigation or in use within integrative cancer care. Dr. Petteruti discusses their proposed mechanisms, clinical rationale, safety considerations, monitoring requirements, and potential interactions. The curriculum differentiates between proposed applications and established outcomes, enabling you to evaluate and communicate information responsibly.

Move Beyond Protocols to Clinical Decision-Making

Cancer care requires individualized assessment rather than a uniform approach. A protocol suitable for one patient may pose unnecessary risks for another. This course guides you in evaluating each case based on diagnosis, disease status, current oncology treatment, organ function, laboratory findings, medications, supplements, treatment objectives, and individual risk factors.

You will develop skills in clinical decision-making rather than applying uniform treatment plans. This includes identifying when additional testing is warranted, when collaboration with the oncology team is necessary, and when complementary therapies are contraindicated.

The curriculum also covers informed consent and effective patient communication. Patients require clear explanations of potential benefits, risks, costs, supporting evidence, and limitations of each therapy. You will learn to set realistic expectations without making unsupported claims or presenting complementary therapies as assured outcomes.

Practical Resources for Your Practice

Advanced IV Cancer Therapy is structured to facilitate the translation of education into organized clinical services. The course provides clinical protocols, patient screening guidance, safety and monitoring considerations, documentation templates, informed consent resources, and supporting research.

These resources support the development of consistent workflows for patient evaluation, treatment planning, infusion administration, follow-up, and documentation. They also offer a framework for training clinical staff and maintaining clear standards throughout your practice.

Who Should Enroll?

This course is intended for licensed healthcare professionals engaged in IV therapy, functional medicine, metabolic medicine, or integrative cancer support. It is suitable for physicians, nurse practitioners, physician associates, nurses practicing under appropriate clinical supervision, and medical directors overseeing infusion services.

Providers should implement all therapies within their professional scope of practice, applicable state regulations, prescribing authority, and established standards of care.